Pages

▼
Tuesday, July 29, 2025

Drug Channels News Roundup, July 2025: 340B vs. Patients, Humira Whiplash, Accumulator Fallout, and Pharmacy Struggles

›
Let’s cut through the steamy summer haze with a refreshing breeze of industry insights from Drug Channels—perfect for pondering while you fl...
Friday, July 25, 2025

Beyond Throughput: Building Reverification Strategies That Safeguard Access

›
Today’s guest post comes from Gregory Morris, Chief Strategy Officer at CareMetx. Gregory examines how Annual Reverification (AR) process...
Tuesday, July 22, 2025

2024 Gross-to-Net Realities at 9 Top Drugmakers: A New Era of Market Access

›
It’s time for Drug Channels ’ annual update on drug pricing trends at the largest pharmaceutical manufacturers. This year’s review includes...
Monday, July 21, 2025

Informa Connect’s Medicaid Drug Rebate Program Summit

›
Informa Connect’s Medicaid Drug Rebate Program Summit September 15-17, 2025 | Chicago, IL Drug Channels readers save 10% with code 25DRCH...
Tuesday, July 15, 2025

Gross-to-Net Bubble Hits $356B in 2024—But Growth Slows to 10-Year Low

›
Is the gross-to-net bubble —the ever-widening gap between brand-name drug sales at list prices and their net revenues after rebates and disc...
Friday, July 11, 2025

Rewriting the Access Script: A Pharmacist’s View on the Rise of Direct-to-Patient

›
Today’s guest post comes from Lindsay Reel, VP of Pharmacy Practice & Specialty Solutions at EVERSANA. In this article, Lindsay share...
Tuesday, July 08, 2025

The Stelara Biosimilar Price War: How PBM-Affiliated Private Labels Are Reshaping the Market

›
The 2025 launch of biosimilars to Johnson & Johnson’s Stelara (ustekinumab) marks another turning point in pharmacy benefit dynamics. Bu...
Tuesday, June 24, 2025

Drug Channels News Roundup, June 2025: PBM Rebate Flow, 340B’s 2024 Boom, IRA Fallout, MFN Legal Risks—and Mark Cuban’s PBM Rant

›
Happy 249th birthday, America! Before you launch your July 4 festivities, Drug Channels humbly offers some fact-based fireworks to heal our...
Friday, June 20, 2025

Transparency vs. Reality: Troubling Lessons from PBM Disclosure Laws (rerun)

›
This week, I’m rerunning some popular posts while I prepare for today’s live video webinar: What’s Next for Retail Pharmacy: Data, Debate, ...
Thursday, June 19, 2025

Mapping the Vertical Integration of Insurers, PBMs, Specialty Pharmacies, and Providers: DCI’s 2025 Update and Competitive Outlook (rerun)

›
This week, I’m rerunning some popular posts while I prepare for tomorrow's live video webinar: What’s Next for Retail Pharmacy: Data, D...
Wednesday, June 18, 2025

The Top 15 Specialty Pharmacies of 2024: How PBMs, Health Systems, and Independents Are Shaping the Market (rerun)

›
This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: What’s Next for Retail Pharmacy: Data, Debate,...
Tuesday, June 17, 2025

The Top Pharmacy Benefit Managers of 2024: Market Share and Key Industry Developments (rerun)

›
This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: What’s Next for Retail Pharmacy: Data, Debate,...